ANTIBIOTIC PROPHYLACTICS ON CURETTAGE FOR PREVENTING PELVIC INFLAMMATORY DISEASE EVENTS: IS IT NECESSARY?

Authors

  • Fauna Herawati Department of Clinical and Community Pharmacy, Faculty of Pharmacy, University of Surabaya, Jalan Raya Kalirungkut, Surabaya, 60293, Indonesia. http://orcid.org/0000-0002-8355-955X
  • Abdul Rahem Department of Community Pharmacy, Faculty of Pharmacy, Airlangga University, Jalan Darmawangsa Dalam, Surabaya, 60286, Indonesia.
  • Dwi Handayani Department of Clinical and Community Pharmacy, Faculty of Pharmacy, University of Surabaya, Jalan Raya Kalirungkut, Surabaya, 60293, Indonesia.
  • Rika Yulia Department of Community Pharmacy, Faculty of Pharmacy, Airlangga University, Jalan Darmawangsa Dalam, Surabaya, 60286, Indonesia.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i11.27817

Keywords:

Antibiotic prophylaxis, Curettage, Obstetrics and gynecology department, Pelvic inflammatory disease

Abstract

Objective: This study aimed to compare pelvic inflammatory disease (PID) symptoms in curettage procedure with three antibiotic prophylaxis strategies.

Methods: The patients were allocated to three Groups (A, B, and C). Group A was patients receiving prophylactic antibiotics and post-curettage antibiotics, Group B received prophylactic antibiotics without post-curettage antibiotics, and Group C did not receive prophylactic antibiotics but received post-curettage antibiotics. The outcomes measured to identify the occurrence of PID symptoms included leukocytes, erythrocyte sedimentation rate, temperature, pain, vaginal discharge, and bleeding.

Results: This study shows that there were no significant differences in any PID symptoms between antibiotic strategies except for pain scale (p=0.03).

Conclusion: The PID symptoms between the three strategies of antibiotic prophylaxis were similar.

Downloads

Download data is not yet available.

Author Biography

Fauna Herawati, Department of Clinical and Community Pharmacy, Faculty of Pharmacy, University of Surabaya, Jalan Raya Kalirungkut, Surabaya, 60293, Indonesia.

Clinical and Community Pharmacy

References

Niranjana ES, Kumar RS, Sudha M, Venkateswaramurthy N. Review on clinically developing antibiotics. Int J Appl Pharm 2018;10:13-8.

Herawati F, Hartono ID, Pranajaya D, Narindra IP. Antibiotic use at primary healthcare centers in Surabaya: A surveillance study. Int J Pharm Pharm Sci 2017;9:41-4.

Muslim Z. Antibiotic prescription to pediatric in hospital Bengkulu, Indonesia: ATC/DDD index. Int J Pharm Pharm Sci 2018;10:31-4.

Wikaningtyas P, Sigit JI, Sukandar EY, Gunawan I. Profile of antibiotic resistance and usage pattern in icu of private hospital in Bandung, Indonesia. Int J Pharm Pharm Sci 2015;7:160-2.

Wright JD, Hassan K, Ananth CV, Herzog TJ, Lewin SN, Burke WM, et al. Use of guideline-based antibiotic prophylaxis in women undergoing gynecologic surgery. Obstet Gynecol 2013;122:1145-53.

American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 120: Use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 2011;117:1472-83.

Van Schalkwkyk J, Van Eyk N. Antibiotic prophylaxis in obstetric procedures. J Obstet Gynaecol Can 2010;32:878-84.

Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med 2015;372:2039-48.

Thinkhamrop J, Laopaiboon M, Lumbiganon P. Prophylactic antibiotics for transcervical intrauterine procedures. Cochrane Database Syst Rev 2007;18:CD005637.

Sweet RL. Treatment strategies for pelvic inflammatory disease. Expert Opin Pharmacother 2009;10:823-37.

Lassey AT, Adanu KR, Newman MJ, Opintah JA. Potential pathogens in the lower genital tract at manual vacuum aspiration for incomplete abortion in Korle Bu Teaching Hospital, Ghana. East Afr Med J 2004;81:398-401.

Al-Ghoweri A, Jumaian N, Ababneh B, Ayoub SS. Efficacy of post-dilatation and curettage antibiotic prophylaxis in women with dysfunctional uterine bleeding in the prevention of pelvic inflammatory disease. J R Med Serv 2007;14:66-8.

Henriques CU, Wilken-Jensen C, Thorsen P, Msller BR. A randomised controlled trial of prophylaxis of post-abortal infection: Ceftriaxone versus placebo. Br J Obstet Gynaecol 1994;101:610-4.

Morrill MY, Schimpf MO, Abed H, Carberry C, Margulies RU, White AB, et al. Antibiotic prophylaxis for selected gynecologic surgeries. Int J Gynaecol Obstet 2013;120:10-5.

Utomo B. Angka Aborsi dan Aspek Psiko-Sosial di Indonesia: Studi di 10 Kota Besar dan 6 Kabupaten. Jakarta: Pusat Penelitian Kesehatan Universitas Indonesia; 2002. p. 7.

Sedgh G, Singh S, Shah IH, Ahman E, Henshaw SK, Bankole A. Induced abortion: Incidence and trends worldwide from 1995 to 2008. Lancet 2012;379:625-32.

Mihirkumar B, Ashley S, Nawaz S, Surekha G, Paarakh PM. Assessment of two or more antibiotics regimen in post-operative surgery. Int J Pharm Pharm Sci 2017;9:188-91.

Low N, Mueller M, Van Vliet HA, Kapp N. Perioperative antibiotics to prevent infection after first-trimester abortion. Cochrane Database Syst Rev 2012;3:CD005217.

Jeppson PC, Park A, Chen CC. Multivalvular bacterial endocarditis after suction curettage abortion. Obstet Gynecol 2008;112 2 Pt 2:452-5.

McKenna T, O’Brien K. Case report: Group B streptococcal bacteremia and sacroiliitis after mid-trimester dilation and evacuation. J Perinatol 2009;29:643-5.

Chang TS, Chen WC, Chen HS, Lee HW. Endogenous Candida endophthalmitis after two consecutive procedures of suction dilatation and curettage. Chang Gung Med J 2002;25:778-82.

Sacks PC, Tchabo JG. Incidence of bacteremia at dilation and curettage. J Reprod Med 1992;37:331-4.

Panke CL, Bonilha MM, Loreto MS, Savaris RF. Incidence of uterine post abortion infection at Hospital de Clínicas de Porto Alegre. Is prophylactic antibiotic necessary? Rev Col Bras Cir 2014;41:100-5.

Makris N, Iatrakis G, Sakellaropoulos G, Rodolakis A, Michalas S. The role of antibiotics after dilatation and curettage in women with metrorrhagia in the prevention of pelvic inflammatory disease. Clin Exp Obstet Gynecol 2000;27:27-8.

Titapant V, Cherdchoogieat P. Effectiveness of cefoxitin on preventing endometritis after uterine curettage for spontaneous incomplete abortion: A randomized controlled trial study. J Med Assoc Thai 2012;95:1372-7.

Published

07-11-2018

How to Cite

Herawati, F., A. Rahem, D. Handayani, and R. Yulia. “ANTIBIOTIC PROPHYLACTICS ON CURETTAGE FOR PREVENTING PELVIC INFLAMMATORY DISEASE EVENTS: IS IT NECESSARY?”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 11, Nov. 2018, pp. 267-9, doi:10.22159/ajpcr.2018.v11i11.27817.

Issue

Section

Original Article(s)